Brief: Windtree Therapeutics Inc - On January 17, John Hamill CFO Notified Co Of His Decision To Resign Effective As Of January 27, 2023
19/01/2023 14:06
Jan 19 (Reuters) - Windtree Therapeutics Inc WINT.O :
* WINDTREE THERAPEUTICS INC - ON JANUARY 17, JOHN HAMILL
CFO
NOTIFIED CO OF HIS DECISION TO RESIGN EFFECTIVE AS OF JANUARY
27, 2023
* WINDTREE THERAPEUTICS INC - ON JAN 18, 2023 BOARD
APPOINTED JOHN
TATTORY AS INTERIM CHIEF FINANCIAL OFFICER, EFFECTIVE AS OF
EFFECTIVE DATE
Further company coverage: WINT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study